Novo Nordisk | NVO - Trade Debtors

Stock Price
37.61
Daily Change
0.70 1.90%
Monthly
-5.43%
Yearly
-42.25%
Q2 Forecast
35.05

Novo Nordisk reported DKK14.27B in Trade Debtors for its fiscal quarter ending in June of 2025.





Trade Debtors Change Date
ANI Pharmaceuticals USD 281.08M 28.46M Dec/2025
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Bausch Health Companies USD 2.35B 66M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 140.42M 113.56M Dec/2025
Corcept Therapeutics USD 59.79M 9.84M Dec/2025
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Merck USD 12.12B 596M Sep/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Novo Nordisk DKK 14.27B 72.1B Jun/2025
Pacira USD 124.07M 8.8M Dec/2025
Perrigo USD 612.8M 31.6M Dec/2025
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 190.46M 8.54M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
Zoetis USD 1.59B 49M Dec/2025